Iolyx Therapeutics
Menlo Park
About Iolyx Therapeutics
Iolyx Therapeutics is a biotechnology research and healthcare service provider for ocular diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $15.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2025)
- Website: iolyx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/iolyx-therapeutics-95835 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.